EUVIMEDEUVIMED entdecken
Crossref

Zinc finger protein 169 promotes tumor progress of hepatocellular cancer via up‐regulating cyclin‐dependent kinase 19

Chaoquan Hu, Aizier Ainiwaer, Ying Lu, Jiaxing Li, Yongmei Fu, Jun Luo, Baijun Wu, Peng Yin, Xiao Hu, Yao Sun, Hong Li, He Lu und 1 weitere

IUBMB Life · 2025

DOI: 10.1002/iub.2943 ↗

Kurz gefasst

Fachartikel in der Zeitschrift IUBMB Life, 2025. Verfasst von Chaoquan Hu und 12 weiteren Autor:innen. Beteiligte Einrichtung: Division of HPB Surgery, Kweichow Moutai Hospital, Renhuai, Guizhou, China. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Gene Expression Regulation, Neoplastic, Cyclin-Dependent Kinases. Die Arbeit nennt 32 Literaturangaben. Gefördert von: Guizhou Provincial Department of Science and Technology Project, Research Grant: Qian Ke He Ji Chu, Kweichow Moutai Hospital Research Grant, Guizhou Provincial Health Commission, Science and Technology Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hepatocellular carcinoma (HCC) ranks among the most prevalent types of cancer globally. Zinc finger protein 169 (ZNF169) holds significant importance as a transcription factor, yet its precise function in HCC remains to be elucidated. This study aims to examine the clinical importance, biological functions, and molecular pathways associated with ZNF169 in the development of HCC. The study employed lentiviral transduction for ZNF169 overexpression and the use of small interfering RNAs (siRNAs) to suppress its expression. ZNF169 was upregulated in HCC tissues and cell lines. Additionally, HCC patients exhibiting elevated ZNF169 levels experienced reduced overall survival, shorter disease‐free survival, and diminished progression‐free survival. Silencing of ZNF169 inhibited cell proliferation, migration, and cell cycle progression. Whereas ectopic expression of ZNF169 promoted HCC progression in vivo and ex vivo. Subsequently, Pearson analysis results showed that cyclin‐dependent kinase 19 (CDK19) was positively correlated with ZNF169 levels in HCC using TCGA dataset. Luciferase assay findings indicated a potential interaction between ZNF169 and CDK19 promoter. Additionally, our data showed that CDK19 expression levels were elevated in HCC tissues, and patients with higher CDK19 expression faced a poorer prognosis. Furthermore, recovery experiments demonstrated that CDK19 could reverse the impact of ZNF169 on HCC cell amplification. Our findings indicate that ZNF169 promotes HCC progression by upregulating CDK19, highlighting its role as a therapeutic target or prognostic biomarker for HCC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularLiver NeoplasmsGene Expression Regulation, NeoplasticCyclin-Dependent KinasesBiomarkers, TumorHumansCell ProliferationMiceAnimalsPrognosisUp-RegulationMaleFemaleCell MovementDisease ProgressionCell Line, TumorMice, NudeMiddle AgedMice, Inbred BALB C

Stichwörter der Autor:innen

cyclin‐dependent kinase 19 (CDK19)hepatocellular cancermalignancyoverall survivalzinc finger protein 169 (ZNF169)

Substanzen

Cyclin-Dependent KinasesBiomarkers, Tumor

Autor:innen und Institutionen

  • Division of HPB Surgery, Kweichow Moutai Hospital, Renhuai, Guizhou, China.
  • Division of HPB Surgery, Affiliated Hospital to Guizhou Medical University, Guiyang, Guizhou, China.
  • Senior Department of Hepatology, the Fifth Medical Center of Chinese PLA General Hospital, Beijing, China.
  • Guizhou Cancer Center, Guizhou Provincial People's Hospital, Guiyang, China.
  • INSERM U1234/Rouen University Normandie, UFR Santé, Rouen, France.
  • National Institute of Health and Medical Research, Medical Research Unit 942/université Sorbonne Paris Nord and Université Paris Cité, Avicenne Hospital, Bobigny, France.

ORCID-Profile: Zheng Dong

Förderung

  • Guizhou Provincial Department of Science and Technology Project, Research Grant: Qian Ke He Ji Chu
  • Kweichow Moutai Hospital Research Grant
  • Guizhou Provincial Health Commission, Science and Technology Foundation
  • Health Commission of Guizhou Province

Zitieren

APA

Hu, C., Ainiwaer, A., Lu, Y., Li, J., Fu, Y., Luo, J., Wu, B., Yin, P., Hu, X., Sun, Y., Li, H., Lu, H., & Dong, Z. (2025). Zinc finger protein 169 promotes tumor progress of hepatocellular cancer via up‐regulating cyclin‐dependent kinase 19. IUBMB Life. https://doi.org/10.1002/iub.2943

Vancouver

Hu C, Ainiwaer A, Lu Y, Li J, Fu Y, Luo J, et al. Zinc finger protein 169 promotes tumor progress of hepatocellular cancer via up‐regulating cyclin‐dependent kinase 19. IUBMB Life. 2025. doi:10.1002/iub.2943

BibTeX
@article{Hu2025,
  author = {Hu, Chaoquan and Ainiwaer, Aizier and Lu, Ying and Li, Jiaxing and Fu, Yongmei and Luo, Jun and Wu, Baijun and Yin, Peng and Hu, Xiao and Sun, Yao and Li, Hong and Lu, He and Dong, Zheng},
  title = {Zinc finger protein 169 promotes tumor progress of hepatocellular cancer via up‐regulating cyclin‐dependent kinase 19},
  journal = {IUBMB Life},
  year = {2025},
  doi = {10.1002/iub.2943}
}
Kostenlos starten →